Nervous young men 'are being forced' to take Viagra Predatory women are destroying the sexual confidence of young men in Ireland -- with some men as young as 20 now turning to Viagra to prop up their flagging libido.A growing 'ladette' culture of women who prefer instant action is proving...
Nervous young men 'are being forced' to take Viagra Predatory women are destroying the sexual confidence of young men in Ireland -- with some men as young as 20 now turning to Viagra to prop up their flagging libido.A growing 'ladette' culture of women who prefer instant action is proving...
The Food and Drug Administration (FDA) - Meeting PM The Food and Drug Administration (FDA) TIME: 8 a.m.EVENT: The Food and Drug Administration (FDA) holds a joint meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Psychopharmacologic Drugs...
'Onward,' Says Chef Recovering From Tongue Cancer EDITOR'S NOTE: CHICAGO - Nick Kokonas, a derivatives trader who retired in his 30s, hit the phones.He made an appointment for his restaurant partner, Grant Achatz, at Memorial Sloan-Kettering Cancer Center in New York the following week....
Clinical contract news in brief GET THE LATEST MARKET REPORTS All market reports 01-Jul-2008 - Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late, involving Parexel, Chiltern, Accelovance and Icon.Parexelnow has a clear...
Alkermes Presents Positive Data on Proprietary Molecules Targeting Opioid Receptors -- Promising Preclinical Results Support Further Development of Novel, Oral Molecules to Treat Central Nervous System Disorders -- CAMBRIDGE, Mass.--(BUSINESS WIRE)--July 1, 2008--Alkermes, Inc.(NASDAQ: ALKS) today announced...
Scripps scientists hope discovery fights Alzheimer's JUPITER Scientists at Scripps Florida have discovered what they hope is a new target for diagnosing and treating Alzheimer's disease.When stressed by heat, starvation or excess sugar, the target leads brain cells to overproduce a...
GSK reviews Montrose API plant GET THE LATEST MARKET REPORTS All market reports 26-Jun-2008 - UK drug major GlaxoSmithKline is examining operations at its active pharmaceutical ingredient (API) manufacturing plant in Montrose, Scotland, with an eye to potential job cuts....
PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies - (NewsRx.com) -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services provider, announced that it is expanding its clinical pharmacology capabilities in the Central Nervous System (CNS)...
GSK reviews Montrose API plant 26-Jun-2008 - UK drug major GlaxoSmithKline is examining operations at its active pharmaceutical ingredient (API) manufacturing plant in Montrose, Scotland, with an eye to potential job cuts.According to various media reports, the...
Weight-Loss Drug Acomplia Approved For NHS Use Despite Suicidal Thoughts In Users A controversial weight-loss drug that is banned in the US has been approved for use on the NHS despite evidence it can prompt suicidal thoughts in users.Drug is used to fight obesity Rimonabant, sold as Acomplia, will be made available to...
Controversial diet drug Rimonabant now available on the NHS in Britain Pharmaceutical News A controversial diet drug has been approved for use on the National Health Service (NHS) in Britain.The obesity drug, Rimonabant also known as Acomplia, has been linked to an increased risk of depression and suicide...
Wonder slimming pill banned in U.S. over suicide fears available on NHS Weight-loss drug banned in the U.S.over fears it can heighten the risk of suicide has been given the go-ahead in Britain.
Acomplia will be available to overweight or obese patients who cannot take, or who have had no success with, the...
Subtle Nervous System Abnormalities Predict Risk of Death in Elderly -- Subtle but clinically detectable neurological abnormalities, such as reduced reflexes and an unstable posture, may be associated with the risk of death and stroke in otherwise healthy older adults, according to a report in the June 23...
Subtle Nervous System Problems Signal Stroke Risk MONDAY, June 23 (HealthDay News) -- In otherwise healthy older people, subtle nervous system problems may signal an increased risk of stroke and death, Italian researchers report.The warning signs can include reduced reflexes, unstable...
Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 32588) - Meeting **New TIME: 8 a.m.EVENT: Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R.
Page 32588) holds a joint meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the...
Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 32588) - Meeting Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R.Page 32588) **New TIME: 8 a.m.
EVENT: Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R.
Page 32588) holds a joint...
Peripheral Neuropathy Therapy: Findings in peripheral neuropathy therapy reported from University of Californi Findings in peripheral neuropathy therapy reported from University of California, Division of Neuroscience (NewsRx.com) -- A new study, 'Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful...
Epilepsy: New epilepsy research from Sungkyunkwan University, Department of Neurology discussed New epilepsy research from Sungkyunkwan University, Department of Neurology discussed (NewsRx.com) -- Research findings, 'Zonisamide decreases cortical excitability in patients with idiopathic generalized epilepsy,' are discussed in a new...
Evotec to Present at the Piper Jaffray Third Annual Europe Conference in London HAMBURG, Germany - Evotec AG (Frankfurt Stock Exchange: EVT, NASDAQ: EVTC) today announced that Jrn Aldag, President & CEO and Dr John Kemp, Chief Research & Development Officer will present at the Piper Jaffray Third Annual Europe...
CIBC World Markets Equity Research Downgrades Target Price of BVF from $12.00 to a Staggering Low of $7.50 Bas TORONTO, June 20 /PRNewswire/ - The Concerned Shareholders remind fellow shareholders of Biovail that it is not too late to vote your YELLOW proxy for a Better Biovail.It is more than clear that change is needed.
Industry experts, CIBC...
2 Billion may Suffer from Mobile Cancer by 2020: Australian Health Research Institute Reports The studies and survey conducted by Australian Health Research Institute indicates that due to billions of times more in volume electromagnetic radiation emitted by billions of mobile phones, internet, intranet and wireless communication...
CIBC World Markets Equity Research Downgrades Target Price of BVF from $12.00 to a Staggering Low of $7.50 Bas Not too late to Protect Your Investment and Vote for A Better Biovail TORONTO, June 20 /PRNewswire/ - The Concerned Shareholders remind fellow shareholders of Biovail that it is not too late to vote your YELLOW proxy for a Better Biovail.
CIBC World Markets Equity Research Downgrades Target Price of BVF from $12.00 to a Staggering Low of $7.50 Bas TORONTO According to CIBC, the reasons for this downgrade include: (x) \'Biovail's poor growth prospects, limited pipeline visibility and our expectation for a long restructuring lead us to believe that Biovail will underperform its peers...
Journal of Clinical Investigation: Molecular changes in brain fluid give insight into brain-damaging disease Molecular changes in brain fluid give insight into brain-damaging disease (NewsRx.com) -- Soon after an individual becomes infected with HIV the virus infects cells in the brain and spinal cord (the central nervous system [CNS]).Although...
